ALS Prevention Grants (neurology worldwide)
The Prevention Grants funded by the ALS Association support translation research worldwide on amyotrophic lateral sclerosis (ALS), specifically with the goal of preventing or delaying
Research funding for medical-related challenges.
The Prevention Grants funded by the ALS Association support translation research worldwide on amyotrophic lateral sclerosis (ALS), specifically with the goal of preventing or delaying
The Scleroderma Foundation Established Investigator Grant provides research funding for established investigators worldwide who have an established research funding record. The funding is intended for
The Pilot and Feasibility Grant funded by the Alpha-1 Foundation support researchers working on alpha-1 antitrypsin (AAT) expression, and the pathogenesis/management of AAT deficiency. The
The Young Investigator Award from the Danish Diabetes Academy (DDA) recognizes the scientific contribution of an early career researcher in Denmark who has improved the
The Danish Diabetes Academy (DDA) is a Denmark-based organization funded by the Novo Nordisk Foundation (NNF). The mission of the DDA is to serve as
The Focused Ultrasound Foundation´s Clinical Awards provide funding for first-in-human and other innovative clinical trials involving the use of image-guided focused ultrasound to treat diseases. Priority
The Bridge Grants funded by the Alpha-1 Foundation support researchers working on alpha-1 antitrypsin (AAT) expression, and the pathogenesis/management of AAT deficiency. Applicants should have
The Focused Ultrasound Foundation´s Pre-Clinical Awards provide funding for investigator-initiated pre-clinical or early-stage research projects involving the use of image-guided focused ultrasound to treat diseases. Applicants
The Lundbeck Foundation Start-up Programme funded by the Lundbeck Foundation facilitates the recruitment of researchers to Denmark from abroad or from industry. The research theme
The Travel Grant funded by the Alpha-1 Foundation supports researchers working on alpha-1 antitrypsin (AAT) deficiency to attend relevant scientific conferences and meetings. Applicants must